Human Galectins Induce Conversion of Dermal Fibroblasts into Myofibroblasts and Production of Extracellular Matrix: Potential Application in Tissue Engineering and Wound Repair

Members of the galectin family of endogenous lectins are potent adhesion/growth-regulatory effectors. Their multi-functionality opens possibilities for their use in bioapplications. We studied whether human galectins induce the conversion of human dermal fibroblasts into myofibroblasts (MFBs) and the production of a bioactive extracellular matrix scaffold is suitable for cell culture. Testing a panel of galectins of all three subgroups, including natural and engineered variants, we detected activity for the proto-type galectin-1 and galectin-7, the chimera-type galectin-3 and the tandem-repeat-type galectin-4. The activity of galectin-1 required the integrity of the carbohydrate recognition domain. It was independent of the presence of TGF-beta 1, but it yielded an additive effect. The resulting MFBs, relevant, for example, for tumor progression, generated a matrix scaffold rich in fibronectin and galectin-1 that supported keratinocyte culture without feeder cells. Of note, keratinocytes cultured on this substratum presented a stem-like cell phenotype with small size and keratin-19 expression. In vivo in rats, galectin-1 had a positive effect on skin wound closure 21 days after surgery. In conclusion, we describe the differential potential of certain human galectins to induce the conversion of dermal fibroblasts into MFBs and the generation of a bioactive cell culture substratum. Copyright (C) 2011 S. Karger AG, Base

Adaptive modelling of coupled hydrological processes with application in water management

This paper presents recent results of a network project aiming at the modelling and simulation of coupled surface and subsurface flows. In particular, a discontinuous Galerkin method for the shallow water equations has been developed which includes a special treatment of wetting and drying. A robust solver for saturated-unsaturated groundwater flow in homogeneous soil is at hand, which, by domain decomposition techniques, can be reused as a subdomain solver for flow in heterogeneous soil. Coupling of surface and subsurface processes is implemented based on a heterogeneous nonlinear Dirichlet-Neumann method, using the dune-grid-glue module in the numerics software Dune

Decomposition of γ-Fe in 0.4C–1.8Si-2.8Mn-0.5Al steel during a continuous cooling process: A comparative study using in-situ HT-LSCM, DSC and dilatometry

Continuous cooling transformation (CCT) diagrams represent roadmaps for producing all heat-treatable steels. CCT curves provide valuable information on the solid-state phase transformation sequence, depending on the defined cooling strategies, the alloying concept of the steel and previous processing steps. The experimental characterization of CCT diagrams is usually done on a laboratory scale applying thermal analysis of dilatometry. In current research studies, however, also other in-situ methods such as high-temperature laser scanning confocal microscopy (HT-LSCM) or differential scanning calorimetry (DSC) are frequently used to investigate phase transformations during thermal cycling. In the present study, HT-LSCM observations and DSC analysis are critically compared with dilatometry results by investigating the CCT diagram of a 0.4%C-1.8%Si-2.8%Mn-0.5%Al (in mass pct.) advanced steel grade. Furthermore, classical examinations by optical microscopy and hardness measurements were performed to support the analysis. In general, very good consistencies between all experimental techniques were identified in determining the transformation start temperature for pearlite, bainite and martensite. The optical microscopy confirmed the observed phase transformations and the results correlated with the measured hardness response. Based on the results, coupling of HT-LSCM and DSC is considered as a valuable novel approach to plot CCT diagrams in future research.Web of Science2

On the constitution and thermodynamic modeling of the phase diagrams Nb-Mn and Ta-Mn

The constitution of the two phase diagrams Nb-Mn and Ta-Mn has been determined from light optical and transmission and scanning electron microscopy (LOM, TEM and SEM) with energy dispersive (EDX) as well as wavelength dispersive (WDX) X-ray spectroscopy, X-ray powder (XPD) and single crystal diffraction (XSCD), differential thermal analysis (DTA) and/or differential scanning calorimetry (DSC). The Laves phases NbMn2 and TaMn2 are the only binary compounds in these systems. High-temperature differential thermal analyses revealed congruent melting for NbMn2 with T,(NbMn2) = 1515 +/- 15 degrees C, whereas TaMn2 melts incongruently with T-m(TaMn2)= 1797 +/- 40 degrees C close to a depleted peritectic reaction. Both Laves phases engage in eutectic reactions l (Mn) + Nb(Ta)Mn-2 (T-eut = 1220 +/- 10 degrees C at 4.9 at% Nb and T-eut = 1234 +/- 10 degrees C at 0.7 at% Ta, respectively). NbMn2 also forms a eutectic with (Nb): l (Nb) + NbMn2 at T-eut = 1493 +/- 15 degrees C and 53.2 at% Nb. Mn shows remarkably large maximum solid solubilities of 19.4 at% Mn in (Nb) as well as of 21.3 at% Mn in (Ta). Detailed atom site distribution has been established for the Laves phases by means of temperature dependent X-ray single crystal data (both C14 - MgZn2-type). Combined data from XPD, EDX/WDX and SEM microstructure indicate that for both Laves phases extended homogeneity regions exist: Nb1+xMn2+x (62.5-73.0 at% Mn at 950 degrees C: -0.19 <= x <= 1.125) and Ta1+xMn2-x (59.5-68.5 at % Mn: -0.055 <= x <= 1.215). Density functional theory (DFT) calculations favor Nb(Ta)/Mn antisite occupation rather than defects. The phases, "NbMn" and "TaMn", adopted earlier in the literature as binary system inherent compounds, were shown (TEM, WDX electron microprobe data and X-ray Rietveld refinements) to be oxygen stabilized phases of the Ti4Ni2O type (so-called eta(eta)-phases) with modified Nb(Ta)/Mn site substitution to comply with the formula Nb(Ta)(3-x)Mn3+xO1-y (defect eta-W3Fe3C-type). From magnetic susceptibility and magnetization measurements, both oxide stabilized eta phases eta-Nb3Mn3O1-y and eta-Ta3Mn3O1-y were found to order ferromagnetically below T-c similar to 77 K, but the Laves phases NbMn2, TaMn2 reveal weakly temperature dependent paramagnetism. No trace of the rhombohedral kyphase (W6Fe7-type) has been encountered in our investigation of the two binary phase diagrams. Thermodynamic and transport properties (specific heat, electrical resistivity and magnetic susceptibility/magnetization) classify the Laves phases with metallic behavior whilst mechanical properties (elastic moduli from DFT and nanoindentation as well as hardness and thermal expansion) group both Laves phases among rather hard and brittle intermetallics. Based on (i) the experimentally derived constitution of the Nb-Mn and Ta-Mn systems, and (ii) on new own DFT data of the energy of formation of the Laves phases, a CALPHAD (CALculation of PHAse Diagrams) calculation of both systems was made providing a complete set of optimized thermodynamic data. Furthermore, the DFT calculations provided information on the instability of the eta-Ta3Mn3 structure and the atom-site specific stabilization effect of oxygen.Web of Science865art. no. 15871

National Network of Depression Centers\u27 Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy

Electroconvulsive therapy (ECT) is a highly therapeutic and cost-effective treatment for severe and/or treatment-resistant major depression. However, because of the varied clinical practices, there is a great deal of heterogeneity in how ECT is delivered and documented. This represents both an opportunity to study how differences in implementation influence clinical outcomes and a challenge for carrying out coordinated quality improvement and research efforts across multiple ECT centers. The National Network of Depression Centers, a consortium of 26+ US academic medical centers of excellence providing care for patients with mood disorders, formed a task group with the goals of promoting best clinical practices for the delivery of ECT and to facilitate large-scale, multisite quality improvement and research to advance more effective and safe use of this treatment modality. The National Network of Depression Centers Task Group on ECT set out to define best practices for harmonizing the clinical documentation of ECT across treatment centers to promote clinical interoperability and facilitate a nationwide collaboration that would enable multisite quality improvement and longitudinal research in real-world settings. This article reports on the work of this effort. It focuses on the use of ECT for major depressive disorder, which accounts for the majority of ECT referrals in most countries. However, most of the recommendations on clinical documentation proposed herein will be applicable to the use of ECT for any of its indications

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine:a pooled post-hoc analysis of two parallel randomized trials

In two pivotal efficacy studies (ZOE-50; ZOE-70), the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster (HZ). Adults aged ≥50 or ≥70 years (ZOE-50 [NCT01165177]; ZOE-70 [NCT01165229]) were randomized to receive 2 doses of RZV or placebo 2 months apart. Vaccine efficacy and safety were evaluated post-hoc in the pooled (ZOE-50/70) population according to the number and type of selected medical conditions present at enrollment. At enrollment, 82.3% of RZV and 82.7% of placebo recipients reported ≥1 of the 15 selected medical conditions. Efficacy against HZ ranged from 84.5% (95% Confidence Interval [CI]: 46.4–97.1) in participants with respiratory disorders to 97.0% (95%CI: 82.3–99.9) in those with coronary heart disease. Moreover, efficacy remained >90% irrespective of the number of selected medical conditions reported by a participant. As indicated by the similarity of the point estimates, this post-hoc analysis suggests that RZV efficacy remains high in all selected medical conditions, as well as with increasing number of medical conditions. No safety concern was identified by the type or number of medical conditions present at enrollment

Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana)

Infectious diseases remain a significant threat to human health, contributing to more than 17 million deaths, annually. With the worsening trends of drug resistance, there is a need for newer and more powerful antimicrobial agents. We hypothesized that animals living in polluted environments are potential source of antimicrobials. Under polluted milieus, organisms such as cockroaches encounter different types of microbes, including superbugs. Such creatures survive the onslaught of superbugs and are able to ward off disease by producing antimicrobial substances. Here, we characterized antibacterial properties in extracts of various body organs of cockroaches (Periplaneta americana) and showed potent antibacterial activity in crude brain extract against methicillin-resistant Staphylococcus aureus and neuropathogenic E. coli K1. The size-exclusion spin columns revealed that the active compound(s) are less than 10 kDa in molecular mass. Using cytotoxicity assays, it was observed that pre-treatment of bacteria with lysates inhibited bacteria-mediated host cell cytotoxicity. Using spectra obtained with LC-MS on Agilent 1290 infinity liquid chromatograph, coupled with an Agilent 6460 triple quadruple mass spectrometer, tissues lysates were analyzed. Among hundreds of compounds, only a few homologous compounds were identified that contained isoquinoline group, chromene derivatives, thiazine groups, imidazoles, pyrrole containing analogs, sulfonamides, furanones, flavanones, and known to possess broad-spectrum antimicrobial properties, and possess anti-inflammatory, anti-tumour, and analgesic properties. Further identification, characterization and functional studies using individual compounds can act as a breakthrough in developing novel therapeutics against various pathogens including superbugs